These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14559387)

  • 21. The role of immunohistochemical adrenomedullin and Bcl-2 expression in development of type-1 endometrial adenocarcinoma: Adrenomedullin expression in endometrium.
    Bozkurt KK; Yalçın Y; Erdemoğlu E; Tatar B; Erdemoğlu E; Çerçi SS; Çiriş İM; Başpınar Ş; Uğuz A; Kapucuoğlu N
    Pathol Res Pract; 2016 May; 212(5):450-5. PubMed ID: 26972419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of PAX2 as a marker for diagnosis of endometrial intraepithelial neoplasia.
    Quick CM; Laury AR; Monte NM; Mutter GL
    Am J Clin Pathol; 2012 Nov; 138(5):678-84. PubMed ID: 23086768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Precursor lesions of endometrial carcinoma].
    Lax SF
    Pathologe; 2019 Feb; 40(1):13-20. PubMed ID: 30707274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
    Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
    Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
    Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
    Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S
    Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia.
    Mutter GL; Zaino RJ; Baak JP; Bentley RC; Robboy SJ
    Int J Gynecol Pathol; 2007 Apr; 26(2):103-14. PubMed ID: 17413975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Campanino MR; Mollo A; De Placido G; Insabato L; Zullo F
    Acta Obstet Gynecol Scand; 2019 Mar; 98(3):275-286. PubMed ID: 30511743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps.
    Lucas E; Niu S; Aguilar M; Molberg K; Carrick K; Rivera-Colon G; Gwin K; Wang Y; Zheng W; Castrillon DH; Chen H
    Am J Surg Pathol; 2023 Sep; 47(9):1019-1026. PubMed ID: 37314146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathology of genetically defined endometrial precancers.
    Mutter GL
    Int J Gynecol Pathol; 2000 Oct; 19(4):301-9. PubMed ID: 11109157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lesions sub-diagnostic of endometrioid intra-epithelial neoplasia/atypical hyperplasia: value of morphology and immunohistochemistry in predicting neoplastic outcome.
    Wyvekens N; Mutter GL; Nucci MR; Kolin DL; Parra-Herran C
    Histopathology; 2024 Oct; 85(4):579-589. PubMed ID: 38785042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New views on hyperplastic endometrial lesions classification--endometrial intraepithelial neoplasia (EIN)].
    Sobczuk A; Wrona M; Pertyński T
    Ginekol Pol; 2007 Dec; 78(12):986-9. PubMed ID: 18411925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YTHDF2 is a novel diagnostic marker of endometrial adenocarcinoma and endometrial atypical hyperplasia/ intraepithelial neoplasia.
    Bian PP; Liu SY; Luo QP; Xiong ZT
    Pathol Res Pract; 2022 Jun; 234():153919. PubMed ID: 35512522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN immunohistochemistry in endometrial hyperplasia: which are the optimal criteria for the diagnosis of precancer?
    Travaglino A; Raffone A; Saccone G; Mascolo M; Pignatiello S; Mollo A; De Placido G; Insabato L; Zullo F
    APMIS; 2019 Apr; 127(4):161-169. PubMed ID: 30803040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience.
    Park CK; Yoon G; Cho YA; Kim HS
    Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of premalignant endometrial disease.
    Mutter GL
    J Clin Pathol; 2002 May; 55(5):326-31. PubMed ID: 11986334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.
    Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
    J Med Assoc Thai; 2008 Aug; 91(8):1161-5. PubMed ID: 18788685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational augmentation of neoplastic endometrial glands in digital pathology displays.
    Papke DJ; Lohmann S; Downing M; Hufnagl P; Mutter GL
    J Pathol; 2021 Mar; 253(3):258-267. PubMed ID: 33165914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
    Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
    Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.
    Mutter GL; Lin MC; Fitzgerald JT; Kum JB; Baak JP; Lees JA; Weng LP; Eng C
    J Natl Cancer Inst; 2000 Jun; 92(11):924-30. PubMed ID: 10841828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.